ORASURE TECHNOLOGIES, INC Cash and Cash Equivalents, Period Increase (Decrease)
ORASURE TECHNOLOGIES, INC (OSUR) reported Cash and Cash Equivalents, Period Increase (Decrease) of $12.89 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-09.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2017-05-09
- ORASURE TECHNOLOGIES, INC cash and cash equivalents, period increase (decrease) for the quarter ending 2017-03-31 was $12.89M, a 2678.45% increase year-over-year.
- ORASURE TECHNOLOGIES, INC cash and cash equivalents, period increase (decrease) for the quarter ending 2016-12-31 was -$3.77M.
- ORASURE TECHNOLOGIES, INC cash and cash equivalents, period increase (decrease) for the quarter ending 2016-09-30 was $6.03M, a 65.12% decline year-over-year.
- ORASURE TECHNOLOGIES, INC cash and cash equivalents, period increase (decrease) for the quarter ending 2016-06-30 was $11.14M.
- ORASURE TECHNOLOGIES, INC cash and cash equivalents, period increase (decrease) for fiscal 2016 was $13.87M, a 1029.99% increase from fiscal 2015.
- ORASURE TECHNOLOGIES, INC cash and cash equivalents, period increase (decrease) for fiscal 2015 was $1.23M.
- ORASURE TECHNOLOGIES, INC cash and cash equivalents, period increase (decrease) for fiscal 2014 was -$324.00K, a 106.11% decline from fiscal 2013.
- ORASURE TECHNOLOGIES, INC cash and cash equivalents, period increase (decrease) for fiscal 2013 was $5.30M, a 91.72% decline from fiscal 2012.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-03-31 | $12.89M 10-Q · filed 2017-05-09 | $9.13M derived: sum of 2 quarters · filed 2017-05-09 | $15.15M derived: sum of 3 quarters · filed 2017-05-09 | $26.29M derived: sum of 4 quarters · filed 2017-05-09 | ||||
| 2016-12-31 | -$3.77M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $2.26M derived: sum of 2 quarters · filed 2017-03-14 | $13.40M derived: sum of 3 quarters · filed 2017-03-14 | $13.87M 10-K · filed 2017-03-14 | ||||
| 2016-09-30 | $6.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $17.17M derived: sum of 2 quarters · filed 2016-11-08 | $17.63M 10-Q · filed 2016-11-08 | $11.05M derived: sum of 4 quarters · filed 2017-05-09 | ||||
| 2016-06-30 | $11.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $11.61M 10-Q · filed 2016-08-08 | $5.02M derived: sum of 3 quarters · filed 2017-05-09 | $22.30M derived: sum of 4 quarters · filed 2017-05-09 | ||||
| 2016-03-31 | $464.00K 10-Q · filed 2017-05-09 | -$6.12M derived: sum of 2 quarters · filed 2017-05-09 | $11.15M derived: sum of 3 quarters · filed 2017-05-09 | $9.01M derived: sum of 4 quarters · filed 2017-05-09 | ||||
| 2015-12-31 | -$6.58M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $10.69M derived: sum of 2 quarters · filed 2017-03-14 | $8.55M derived: sum of 3 quarters · filed 2017-03-14 | $1.23M 10-K · filed 2017-03-14 | ||||
| 2015-09-30 | $17.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $15.13M derived: sum of 2 quarters · filed 2016-11-08 | $7.81M 10-Q · filed 2016-11-08 | $6.82M derived: sum of 4 quarters · filed 2017-03-14 | ||||
| 2015-06-30 | -$2.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$9.46M 10-Q · filed 2016-08-08 | -$10.45M derived: sum of 3 quarters · filed 2017-03-14 | $7.57M derived: sum of 4 quarters · filed 2017-03-14 | ||||
| 2015-03-31 | -$7.32M 10-Q · filed 2016-05-10 | -$8.31M derived: sum of 2 quarters · filed 2017-03-14 | $9.71M derived: sum of 3 quarters · filed 2017-03-14 | $1.35M derived: sum of 4 quarters · filed 2017-03-14 | ||||
| 2014-12-31 | -$988.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $17.04M derived: sum of 2 quarters · filed 2017-03-14 | $8.67M derived: sum of 3 quarters · filed 2017-03-14 | -$324.00K 10-K · filed 2017-03-14 | ||||
| 2014-09-30 | $18.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $9.66M derived: sum of 2 quarters · filed 2015-11-06 | $664.00K 10-Q · filed 2015-11-06 | $11.27M derived: sum of 4 quarters · filed 2015-11-06 | ||||
| 2014-06-30 | -$8.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$17.36M 10-Q · filed 2015-08-07 | -$6.76M derived: sum of 3 quarters · filed 2015-08-07 | -$1.13M derived: sum of 4 quarters · filed 2015-08-07 | ||||
| 2014-03-31 | -$9.00M 10-Q · filed 2015-05-08 | $1.60M derived: sum of 2 quarters · filed 2015-05-08 | $7.23M derived: sum of 3 quarters · filed 2015-05-08 | $4.92M derived: sum of 4 quarters · filed 2015-05-08 | ||||
| 2013-12-31 | $10.60M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $16.23M derived: sum of 2 quarters · filed 2015-03-12 | $13.91M derived: sum of 3 quarters · filed 2015-03-12 | $5.30M 10-K · filed 2016-03-14 | ||||
| 2013-09-30 | $5.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $3.31M derived: sum of 2 quarters · filed 2014-11-07 | -$5.30M 10-Q · filed 2014-11-07 | -$6.83M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-06-30 | -$2.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | -$10.92M 10-Q · filed 2014-08-06 | -$12.45M derived: sum of 3 quarters · filed 2015-03-12 | $53.69M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-03-31 | -$8.61M 10-Q · filed 2014-05-08 | -$10.14M derived: sum of 2 quarters · filed 2015-03-12 | $56.00M derived: sum of 3 quarters · filed 2015-03-12 | $56.46M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2012-12-31 | -$1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $64.61M derived: sum of 2 quarters · filed 2015-03-12 | $65.07M derived: sum of 3 quarters · filed 2015-03-12 | $64.01M 10-K · filed 2015-03-12 | ||||
| 2012-09-30 | $66.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $66.60M derived: sum of 2 quarters · filed 2013-11-07 | $65.54M 10-Q · filed 2013-11-07 | $65.54M 10-Q · filed 2012-11-09 | $68.04M derived: sum of 4 quarters · filed 2014-03-14 | |||
| 2012-06-30 | $459.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$605.00K 10-Q · filed 2013-08-08 | -$605.42K 10-Q · filed 2012-08-08 | $1.90M derived: sum of 3 quarters · filed 2014-03-14 | -$52.13M derived: sum of 4 quarters · filed 2014-03-14 | |||
| 2012-03-31 | -$1.06M 10-Q · filed 2013-05-09 | -$1.06M 10-Q · filed 2012-05-09 | $1.44M derived: sum of 2 quarters · filed 2014-03-14 | -$52.59M derived: sum of 3 quarters · filed 2014-03-14 | -$47.73M derived: sum of 4 quarters · filed 2014-03-14 | |||
| 2011-12-31 | $2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | -$51.52M derived: sum of 2 quarters · filed 2014-03-14 | -$46.67M derived: sum of 3 quarters · filed 2014-03-14 | -$49.97M 10-K · filed 2014-03-14 | -$49.97M 10-K · filed 2012-03-14 | |||
| 2011-09-30 | -$54.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$49.17M derived: sum of 2 quarters · filed 2012-11-09 | -$52.47M 10-Q · filed 2012-11-09 | -$50.32M derived: sum of 4 quarters · filed 2013-03-13 | ||||
| 2011-06-30 | $4.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $1.56M 10-Q · filed 2012-08-08 | $3.70M derived: sum of 3 quarters · filed 2013-03-13 | $2.85M derived: sum of 4 quarters · filed 2013-03-13 | ||||
| 2011-03-31 | -$3.30M 10-Q · filed 2012-05-09 | -$1.15M derived: sum of 2 quarters · filed 2013-03-13 | -$2.01M derived: sum of 3 quarters · filed 2013-03-13 | |||||
| 2010-12-31 | $2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-13 | $1.29M derived: sum of 2 quarters · filed 2013-03-13 | -$1.09M 10-K · filed 2013-03-13 | -$1.09M 10-K · filed 2012-03-14 | ||||
| 2010-09-30 | -$852.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | -$3.24M 10-Q · filed 2011-11-09 | ||||||
| 2010-06-30 | -$2.38M 10-Q · filed 2011-08-05 | |||||||
| 2009-12-31 | $35.37M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |